GUSB pseudogene 14 (GUSBP14)

GUSB pseudogene 14 (GUSBP14) is a human pseudogene. It is not a protein-coding gene and is believed to be nonfunctional in terms of producing an active protein. There are computational predictions that suggest potential involvement in nervous system development, skeletal system development, and the glucuronoside catabolic process, but these are speculative and not demonstrated experimentally. It is not recognized as a functional therapeutic target, receptor, enzyme, transporter, or related protein. GUSBP14 is characterized as a pseudogene, a segment of genomic DNA resembling a gene but typically nonfunctional—i.e., it does not produce a functional protein product. It is predicted (computationally) to be involved in nervous system and skeletal system development, and activities such as beta-glucuronidase activity and carbohydrate binding, but these are inferred and not proven in functional experiments. Common aliases include SMA4 and SMA3, but there is no substantial literature tying these to disease mechanisms or validated biological roles for GUSBP14 specifically. GUSBP14 is not referenced as a drug target in the primary pharmacological, genetic, or genomic databases, and no interacting drugs, mechanisms of action, or biomarker uses are reported. The correct gene for beta-glucuronidase activity and related disease relevance (such as in mucopolysaccharidosis type VII) is GUSB, not GUSBP14. Many pseudogenes exist for GUSB in the human genome, with GUSBP14 being one. GUSBP14 is frequently confused with GUSB due to name similarity, but it is not a therapeutic target or enzyme itself, just a nonfunctional genetic relic. No evidence was found linking GUSBP14 with the functions or disease roles associated with GUSB. No mechanism, biomarker, or drug interaction data exists for GUSBP14. Summary: GUSBP14 (GUSB pseudogene 14) is a nonfunctional pseudogene, not a therapeutic target or receptor, and should not be confused with the functional GUSB gene (Glucuronidase beta), which is an enzyme related to lysosomal degradation of glycosaminoglycans and certain diseases.

Other names

SMA4SMA3